Your browser doesn't support javascript.
loading
DR10601, a novel recombinant long-acting dual glucagon-like peptide-1 and glucagon receptor agonist for the treatment of obesity and type 2 diabetes mellitus.
Wang, W; Wen, X; Duan, W; Wang, X; Chen, Y; Dong, J; Yang, Z; Fang, J; Zhou, Z; Yao, G; Fang, Y; Huang, Y.
Afiliación
  • Wang W; Department of Pharmacy, College of Life Sciences, China Jiliang University, Hangzhou, Zhejiang, China.
  • Wen X; Zhejiang Doer Biologics Corporation, No. 452 Avenue 6, Hangzhou Economic and Technological Development Zone, Hangzhou, 310018, Zhejiang, China.
  • Duan W; Zhejiang Doer Biologics Corporation, No. 452 Avenue 6, Hangzhou Economic and Technological Development Zone, Hangzhou, 310018, Zhejiang, China.
  • Wang X; Zhejiang Doer Biologics Corporation, No. 452 Avenue 6, Hangzhou Economic and Technological Development Zone, Hangzhou, 310018, Zhejiang, China.
  • Chen Y; Zhejiang Doer Biologics Corporation, No. 452 Avenue 6, Hangzhou Economic and Technological Development Zone, Hangzhou, 310018, Zhejiang, China.
  • Dong J; Zhejiang Doer Biologics Corporation, No. 452 Avenue 6, Hangzhou Economic and Technological Development Zone, Hangzhou, 310018, Zhejiang, China.
  • Yang Z; Zhejiang Doer Biologics Corporation, No. 452 Avenue 6, Hangzhou Economic and Technological Development Zone, Hangzhou, 310018, Zhejiang, China.
  • Fang J; Zhejiang Doer Biologics Corporation, No. 452 Avenue 6, Hangzhou Economic and Technological Development Zone, Hangzhou, 310018, Zhejiang, China.
  • Zhou Z; Zhejiang Doer Biologics Corporation, No. 452 Avenue 6, Hangzhou Economic and Technological Development Zone, Hangzhou, 310018, Zhejiang, China.
  • Yao G; Zhejiang Doer Biologics Corporation, No. 452 Avenue 6, Hangzhou Economic and Technological Development Zone, Hangzhou, 310018, Zhejiang, China.
  • Fang Y; Zhejiang Doer Biologics Corporation, No. 452 Avenue 6, Hangzhou Economic and Technological Development Zone, Hangzhou, 310018, Zhejiang, China.
  • Huang Y; Zhejiang Doer Biologics Corporation, No. 452 Avenue 6, Hangzhou Economic and Technological Development Zone, Hangzhou, 310018, Zhejiang, China.
J Endocrinol Invest ; 43(5): 653-662, 2020 May.
Article en En | MEDLINE | ID: mdl-31786794
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Glucagón / Fármacos Antiobesidad / Diabetes Mellitus Tipo 2 / Péptido 1 Similar al Glucagón / Hipoglucemiantes / Obesidad Límite: Animals / Humans / Male Idioma: En Revista: J Endocrinol Invest Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Glucagón / Fármacos Antiobesidad / Diabetes Mellitus Tipo 2 / Péptido 1 Similar al Glucagón / Hipoglucemiantes / Obesidad Límite: Animals / Humans / Male Idioma: En Revista: J Endocrinol Invest Año: 2020 Tipo del documento: Article País de afiliación: China